[go: up one dir, main page]

WO2001072342A1 - Gastric emptying test-kit and method of testing gastric emptying of solid meal - Google Patents

Gastric emptying test-kit and method of testing gastric emptying of solid meal Download PDF

Info

Publication number
WO2001072342A1
WO2001072342A1 PCT/BE2001/000050 BE0100050W WO0172342A1 WO 2001072342 A1 WO2001072342 A1 WO 2001072342A1 BE 0100050 W BE0100050 W BE 0100050W WO 0172342 A1 WO0172342 A1 WO 0172342A1
Authority
WO
WIPO (PCT)
Prior art keywords
test
premix
gastric emptying
meal
labeled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BE2001/000050
Other languages
French (fr)
Inventor
Yvo Ghoos
Benny Geypens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to AU2001243965A priority Critical patent/AU2001243965A1/en
Publication of WO2001072342A1 publication Critical patent/WO2001072342A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/497Physical analysis of biological material of gaseous biological material, e.g. breath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • A61K49/1815Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206Administration of radioactive gases, aerosols or breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1296Radioactive food, e.g. chocolates, drinks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Definitions

  • This invention generally relates to a kit for testing gastric emptying of solids and more specifically to stable isotope labeled of medium chain fatty acid incorporated in a dry premix. More specifically it involves the improvement of the classic 13 C-octanoic acid egg-omelet breath test, wherein the I3 C,tracer had to be incorporated in a fresh test meal and the yolk phase and egg white phases had initially to be separated during baking of the omelet.
  • a dry premix can be prepared, comprising a mixture of the labeled egg yolk and egg white, for easy instant and in situ preparation of a test meal according to a standardized method and for reliable diagnosis of solid phase gastric emptying by monitoring the appearance of CO 2 in breath.
  • Digestion of all foods in humans and other mammals begins in the stomach where both solid and liquid matter is mixed with gastric juices that are secreted by the stomach walls.
  • the gastric juice is predominately hydrochloric acid, but also includes enzymes that break down food constituents so that they can be absorbed and used.
  • the contents of the stomach are emptied into the small intestine via the pyloric sphincter, which opens and closes to release pulses of the mixed solids and liquids.
  • the rate of such emptying is regulated by this sphincter.
  • the rate is determined by the caloric content of the meal. The higher the caloric content, the lower the rate of discharge.
  • the solid phase of the food must undergo reduction in particle size, which is caused by contractions of the stomach walls until a particle size of about 1 mm in diameter is attained.
  • a disorder in the rate of gastric emptying can result either in too rapid or in delayed emptying.
  • the rate is accelerated the food is "dumped" into the small intestine prematurely.
  • the time required to empty the stomach is excessive. Delayed gastric emptying often is encountered in diabetic patents and may be associated with abdominal pain, cramping and bloating.
  • Even healthy people often notice subjective gastric symptoms (sinking feelings, heartburn, anorexia, etc.) in the everyday life. It has been estimated that symptoms of functional gastrointestinal disorders, those without noticeable structural, infectious, or biochemical cause, occur to some degree in nearly on quarter of all individuals who are otherwise healthy. Gastric symptoms are also caused by stress, overeating, excessive intake of alcoholic drinks and intake of drugs.
  • gastric emptying of the meal can be considered a limiting step in 13 CO 2 excretion after ingestion of a C-octanoic acid labelled solid meal.
  • an average function can be used to describe the postgastric processing of octanoic acid.
  • Metabolism of octanoic acid remains unaltered not only in healthy volunteers but also in other circumstances, as has been shown for insulin-dependent diabetes mellitus (11) or after administration of octreotide (12) l3 C-octanoic had initially been selected for testing gastric emptying by a breath test since it has been shown for a long time that octanoic acid, an eight-carbon fatty acid found in dietary fats, is rapidly absorbed from the intestine and carried to the liver via the portal venous system, where it is rapidly and completely oxidised.
  • 13 C-octanoic a iJl WJPQiowever.
  • the labeled single cell marker organisms were then mixed in a batter with proteins, lipids or carbohydrates and were baked into a biscuit for ingestion by the patient.
  • this techniques could overcome the disadvantages of inconvenience and standardization related to fresh, meal preparation and to egg white / egg yolk separation in the classic egg-omelet breath test, it still requires a controllable alga culture process in a photosynthetic reaction tank with nutrient solutions and 13 CO 2 gas input. The inconsistency of such life process may affect the reliability of the final test product.
  • growing photosynthetic alga in an air atmosphere enriched with 13 CO 2 atmosphere will result in the incorporation 13 C atom in a variety of functional and structural proteins, fat and carbohydrate macromolecules. Because of their varied chemistry and physical form the rate and extent to which the different types of nutrients are digested in and absorbed from the small intestine and the metabolism of the different fatty acids, amino acids or sugars will vary.
  • the CO 2 breath test is an indirect measurement of gastric emptying since the CO 2 appearance curve reflects the sum influence of gastric emptying, digestion, absorption and metabolism.
  • the availability, absorption and metabolic processing of a labeled compound must thus be fast and reproducible to obtain only gastric emptying as rate limiting step. This is obtained with octanoic acid in particular and likely with other medium chain fatty acids, since they are absorbed by the small intestine and are rapidly transported to the liver bound to serum albumin for free entering in the mitochondria and fast oxidation to CO 2 .
  • These features make medium chain fatty acids, on condition that they are not freely available in the stomach, suitable for measuring gastric emptying.
  • test meal as prepackaged food in such a way that a test-kit can be composed, which allows the measurement of gastric emptying out of the hospital with results, equally good as the "standard" egg-omelet meal.
  • the present meal containing the 13 C,octanoic acid, is a powder, to which water is added to obtain a batter.
  • the batter allows to bake a pancake, which upon digestion is equally reliable as the omelet to measure gastric emptying by 13 CO 2 breath test.
  • the pancake-powder has been prepared following the hygienic procedures, common in food industries. It is packed water- free, kept under nitrogen and wrapped in aluminum foil.
  • the test-kit is further composed of test tubes and all information to execute the test properly.
  • Figure 1 shows individual paired data for gastric half emptying time (tl/2g) in a test using the egg & bread meal (Test I) and the pancake
  • Test meal The pancake-powder is composed per unit pancake in the following way:
  • group A the individuals, as described in the publication
  • group B the individuals as described in ref 2.
  • group C sixteen normal individuals took a pancake, of which the powder has been prepared by the laboratory personnel.
  • group D eight normal individuals took a pancake, of which the premix powder has been prepared in an industrial manner by Ovofood, Herk-de-Stad, Belgium.
  • the test is preferably executed in the morning (at starvation).
  • the patients stay in rest during the test, although a slow walk is permitted. They stay in upright position the first two hours of the test; after that time more conformable position may be adopted, but never they are allowed to lie down.
  • the patients keep the $trftW- > £t the Bottom c ⁇ ftfae
  • the tube is immediately closed thereafter.
  • the test is performed as follows:
  • the patients blow in the first vial and half a minute thereafter in vial 2.
  • the pancake is eaten within 10 minutes.
  • small quantities (20 ml) of drinks can be taken, just to cut thirst. 15 minutes after the end of the meal the patients blow in the next tube. 30 minutes after the end of the meal the patients blow into tube 4. Every 15 minutes thereafter the patients blow in the next tube, up to 4 hours (240 min). The test end after 4 hours.
  • Test I involved the classic gastric emptying breath test meal. In the preparation of this meal, 100 ⁇ l 13C-octanoic acid is mixed in one egg yolk. This yolk is then baked in a pan and then the white of the egg is added to bake. The meal is eaten in maximum 10 minutes with 3 slices of white bread and 1 glass (150 ml) of water.
  • the so obtained batter was then baked in a pan with 3 g of margarine.
  • the subject ate the pancake with 5 g of caster sugar in maximum 10 minutes and with a glass of water.
  • Breath samples were taken via a drinking straw held inside a tube (exetainer). Before the meal 2 samples were obtained and after the meal every 15 minutes for a total duration of 4 hours. Samples were measured by continuous flow isotope ratio mass spectrometry (ABCA 20-20, PDZ Europas, Crewe, UK). From the obtained deltal3 values the Percent Dose Recovery was calculated and a model was fit by the method of least squares. From this method the time of half emptying of the stomach (tl/2g) was calculated including a correction for post gastric processing of the label.
  • test-kit Measuring gastric emptying in children, adults and elderly people in the hospital.
  • the test can be sent to other hospitals as a test-kit , and can even be taken at home to have the test done by the patient at the time, which is the most convenient for him(her).
  • test can be considered reference method to demonstrate gastric emptying in different pathological conditions.
  • test meal pancake powder
  • other tracer molecules can be added to study gastrointestinal functions, other than gastric emptying, e.g. assimilation of carbohydrates, lipids, proteins, oro-cecal transit, bacterial overgrowth or/and fermentation processes in the colon.
  • test can be taken as reference method for testing and developing drugs, affecting gastrointestinal motility and transit.
  • test can also be taken as reference method to demonstrate gastric emptying of food formula.
  • Triglycerides edited by JR. Senior. Philadelphia, PA: Univeristy of Pennsylvania, 1968, p. 39 - 49. 11) Maes, B.D. Measurement of gastric emptying using dynamic breath analysis, edited by B.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Atmospheric Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

This invention relates generally to development of Kit with a pre-packed premix that contains medium chain fatty acids labeled with stable isotope on a suitable carrier and mixed with suitable ingredients. The premix is a part of the kit that provides all materials needed to diagnose solid phase gastric emptying by monitoring the appearance if 13CO2 in breath. More specifically, the invention relates to an improvement of the current 13C-octanoic acid egg-omelet breath test, which is generally accepted as adequate, but which lacks uniformity and convenience of use. The 13C, octanoic acid premix of the test kit can be stored long term at room temperature and provides simplified and reliable tools to standardize measure and simplify the octanoate breath test.

Description

Gastric emptying test-kit and method of testing gastiic emptying of solid meal
FIELD OF THE INVENTION
This invention generally relates to a kit for testing gastric emptying of solids and more specifically to stable isotope labeled of medium chain fatty acid incorporated in a dry premix. More specifically it involves the improvement of the classic 13C-octanoic acid egg-omelet breath test, wherein the I3C,tracer had to be incorporated in a fresh test meal and the yolk phase and egg white phases had initially to be separated during baking of the omelet. In present invention it is surprisingly found that a dry premix can be prepared, comprising a mixture of the labeled egg yolk and egg white, for easy instant and in situ preparation of a test meal according to a standardized method and for reliable diagnosis of solid phase gastric emptying by monitoring the appearance of CO2 in breath.
BACKGROUND OF THE INVENTION
Digestion of all foods in humans and other mammals begins in the stomach where both solid and liquid matter is mixed with gastric juices that are secreted by the stomach walls. The gastric juice is predominately hydrochloric acid, but also includes enzymes that break down food constituents so that they can be absorbed and used. The contents of the stomach are emptied into the small intestine via the pyloric sphincter, which opens and closes to release pulses of the mixed solids and liquids. The rate of such emptying is regulated by this sphincter. The rate is determined by the caloric content of the meal. The higher the caloric content, the lower the rate of discharge. In addition, the solid phase of the food must undergo reduction in particle size, which is caused by contractions of the stomach walls until a particle size of about 1 mm in diameter is attained.
A disorder in the rate of gastric emptying can result either in too rapid or in delayed emptying. When the rate is accelerated the food is "dumped" into the small intestine prematurely. When delayed, the time required to empty the stomach is excessive. Delayed gastric emptying often is encountered in diabetic patents and may be associated with abdominal pain, cramping and bloating. Even healthy people often notice subjective gastric symptoms (sinking feelings, heartburn, anorexia, etc.) in the everyday life. It has been estimated that symptoms of functional gastrointestinal disorders, those without noticeable structural, infectious, or biochemical cause, occur to some degree in nearly on quarter of all individuals who are otherwise healthy. Gastric symptoms are also caused by stress, overeating, excessive intake of alcoholic drinks and intake of drugs. Additional major causes of the complaints about the digestive tracts include maldigestion, chronic gastritis, delayed gastric emptying after meals, gastric hyperacidity and peptic ulcers which bring about subjective symptoms such as abdominal swelling feelings, unpleasantness in the upper abdomen, anorexia, heartburn and belching (eructation). These functional disorders, often caused by delayed gastric emptying, require an objective, practical and efficient tests to measure gastric emptying.
In previous studies (1,2) it has been demonstrated that gastric emptying can be measured accurately by means of the 13C,octanoic acid egg-omelet breath test. The i3C,tracer is incorporated in a test meal, which consists of an egg omelet and three slices of breath. The test represents real advantage over the radiolabeled test meal methods to measure gastric emptying, i.e. radioscintigraphy, as it can be applied in all patients as no exposure to radioactivity is involved. Furthermore the test is simple to be performed by the patient, and several tests can be executed in the same time. By this, it represents cost-savings of instrumentation and personnel also. The use of the above non-radioactive substrates has been validated against the prior radiological methods with high correlation (1,3). With the breath test with 13C-octanoic acid "standard" egg-omelet it has been demonstrated that postgastric processing of 13C-octanoic acid until 13CO2 exhalation occurs very rapidly, with -minimal intersubject variability. This is due to the very rapid absorption from the small intestine, to quick transport to the liver (no mucosal esterification, no incorporation in chylomicrons (3, 6, - 8), and to a ready and almost complete oxidation to l3CO2 in the liver (no requirement for carnitine to cross the double mitochondrial membrane (9,10)). Therefore, gastric emptying of the meal can be considered a limiting step in 13CO2 excretion after ingestion of a C-octanoic acid labelled solid meal. Also an average function can be used to describe the postgastric processing of octanoic acid. Metabolism of octanoic acid remains unaltered not only in healthy volunteers but also in other circumstances, as has been shown for insulin-dependent diabetes mellitus (11) or after administration of octreotide (12) l3C-octanoic had initially been selected for testing gastric emptying by a breath test since it has been shown for a long time that octanoic acid, an eight-carbon fatty acid found in dietary fats, is rapidly absorbed from the intestine and carried to the liver via the portal venous system, where it is rapidly and completely oxidised. For testing the gastric emptying of the solid food by the non-radioactive markers, 13C-octanoic a iJl WJPQiowever. to bgdflrgjested in a freshly baked egg sandwich. The physician has thus to prepare the meal before the test administration. The nature of such a procedure makes the development of a standard solid-phase emptying protocol or procedure difficult, and hinders the commercial development of an office-based procedure. A prepared and pre-packaged test kit would have the advantage of storage at room temperature, instant availability and ease of transportation to the place of an experimental set up for in situ diagnosis. However, this development was hindered by the fact that as a rule the egg yolk homogenized with 13C-octanioc acid had to be baked separately from the egg white to ensure a firm retention of the label in the solid phase of the meal (1). To overcome the problems mentioned above with the current 13C,octanoic acid breath test and to avoid the use of radioactive tracer, Klein Peter D, 1989 (4) proposed the use of single cell organisms as markers for solid-phase meals. The intrinsically labeled single cell marker organisms, proteins, lipids or carbohydrates were incorporated into a baked product that is ingested by the patient. The product containing the marker organisms was a biscuit having an edible photosynthetic alga therein, such as Spirulina platensis. The alga had to be photosynthetic and had to be grown in an atmosphere of about 99% 13CO2, so that as a consequence of the photosynthetic process all carbon atoms contained in the alga would be 13C. The labeled single cell marker organisms were then mixed in a batter with proteins, lipids or carbohydrates and were baked into a biscuit for ingestion by the patient. Although this techniques could overcome the disadvantages of inconvenience and standardization related to fresh, meal preparation and to egg white / egg yolk separation in the classic egg-omelet breath test, it still requires a controllable alga culture process in a photosynthetic reaction tank with nutrient solutions and 13 CO2 gas input. The inconsistency of such life process may affect the reliability of the final test product. Furthermore, growing photosynthetic alga in an air atmosphere enriched with 13CO2 atmosphere will result in the incorporation 13C atom in a variety of functional and structural proteins, fat and carbohydrate macromolecules. Because of their varied chemistry and physical form the rate and extent to which the different types of nutrients are digested in and absorbed from the small intestine and the metabolism of the different fatty acids, amino acids or sugars will vary.
The CO2 breath test is an indirect measurement of gastric emptying since the CO2 appearance curve reflects the sum influence of gastric emptying, digestion, absorption and metabolism. The availability, absorption and metabolic processing of a labeled compound must thus be fast and reproducible to obtain only gastric emptying as rate limiting step. This is obtained with octanoic acid in particular and likely with other medium chain fatty acids, since they are absorbed by the small intestine and are rapidly transported to the liver bound to serum albumin for free entering in the mitochondria and fast oxidation to CO2. These features make medium chain fatty acids, on condition that they are not freely available in the stomach, suitable for measuring gastric emptying. The proteins of single cell organisms, however will undergo a complex series of degradative processes which are elucidated by the hydrolytic enzymes originating from the stomach, pancreas and the brush border of the small intestine. Pancreatic digestion plays a critical role in the overall protein assimilation. Since it has been previously been demonstrated by a 13C-labeled protein meal ingestion and 13CO2 exhalation, that protein assimilation and not the metabolism of the amino acids is the rate limiting step, 13C-labeled protein test can be considered a promising test for the evaluation of the digestibility of protein and the evaluation and the follow up of exocrine pancreatic function (13) but not for measurement of gastric emptying, especially not for patients with malabsorption symptoms. For instance with 13C egg white, generally considered to be highly digestible, there exists in a breath test a very good correlation between the 13CO2 production and the pancreatic trypsin output in the duodenum (13). Nevertheless, not all egg white proteins are well absorbed. Some undergo additional fermentation in the colon, which results in CO2 release, origination from bacterial metabolism (20). There is thus a need for a safe, practical, accurate and ease to standardize test to diagnosis of gastric emptying of solids. This invention provides these features by improvement the classic l3C-octanoic acid egg-omelet test (in use since the early nineties) to a test kit with a dry 13C-
1 "^ octanoic acid premix. This was a challenge since in the classic egg-omelet test C octanoic acid enriched yolk and egg white has to baked separately to avoid that 13C is released and absorbed in the stomach. In the kit of present invention, both fractions of the egg, i.e. egg white and labeled yolk, are in the same powder mix, without loosing the diagnostic properties.
SUMMARY OF THE INVENTION
For the classic octanoic acid breath test, 13C,tracer is incorporated in a test meal, which consists of an egg omelet and three slices of bread. This meal has to be prepared just before the test starts. By consequence the patients have to come to the laboratory unit, where the test meal is served. During 4 hours the patient stays at the laboratory and is asked to blow in a tube every 15 minutes. Present invention involves the development of a test-kit that can be send as such to other hospitals, and even the patient can take the test-kit at home where the test can be executed at time, convenient for the patient. Until now this was not possible for the C.octanoic acid breath test, since the present test meal, i.e. egg omelet had to be prepared freshly by homogenizing of 13C-octanoic acid in yolk and baking it separately from the egg white just before the test started (1,2, 3, 5, 12 - 19)
By this invention we present for the first time the test meal as prepackaged food in such a way that a test-kit can be composed, which allows the measurement of gastric emptying out of the hospital with results, equally good as the "standard" egg-omelet meal.
The present meal, containing the 13C,octanoic acid, is a powder, to which water is added to obtain a batter. The batter allows to bake a pancake, which upon digestion is equally reliable as the omelet to measure gastric emptying by 13CO2 breath test. The pancake-powder has been prepared following the hygienic procedures, common in food industries. It is packed water- free, kept under nitrogen and wrapped in aluminum foil. The test-kit is further composed of test tubes and all information to execute the test properly.
Advantages are double: first, the patients are not obliged to come to the hospital; upon instructions the test can even be executed at home. Second, it is guaranteed that the powder is kept fresh for more than one year. In the present study we prove that the novel test meal (pancake-powder) is equally good as the omelet meal to measure gastric emptying by 13CO breath test.
BRIEF DESCRIP ION OF THE DRAWNINGS
Figure 1: shows individual paired data for gastric half emptying time (tl/2g) in a test using the egg & bread meal (Test I) and the pancake
Figure 2: demonstrates Altman-Bland plot showing difference versus mean of gastric half emptying time for the test with egg & bread (testl) and the test with the pancake from a premix (test II); dotted line = mean DESCRIPTION OF THE PREFERED EMBOtlWIfTOrrS OF TH flWyJRNTTON
EXPERIMENTAL
Example 1 Production of the pre-packed test kit
Test meal: The pancake-powder is composed per unit pancake in the following way:
In laboratory conditions, per 8.6 g egg yolk 100 microliter 13C,octanoic acid is added and mixed for homogeneous distribution of the tracer in the yolk-material, consequently this is lyophilized. Consequently this is mixed with 3.75 g lyophilized egg white, 17 g wheat flour and 3 g milk powder. A total weight of the powder is 32.35 g; it represents 179.1 kcal. The premix is used in this amounts to prepare one pancake. The same premix has, however, also been prepared on lager scale by Ovofood, Herk-de-Stad, Belgium. An aluminum sachet with premix in the amount to prepare one pancake makes part of the test kit. To make the pancake 32.35 g of the powder premix is suspended in 70 ml of water, and the batter is baked in the pan by addition of 3 g fat. The pancake is served with an additional amount of 5 g (beet)sugar as sweetener. Total caloric intake is 225.1 kcal.
Example 2 Measuring gastric emptying of the solid phase with the pre-packed test kit
Subjects: There are four groups of normal individuals involved in the comparative study: group A: the individuals, as described in the publication (1) group B: the individuals as described in ref 2. group C: sixteen normal individuals took a pancake, of which the powder has been prepared by the laboratory personnel. group D: eight normal individuals took a pancake, of which the premix powder has been prepared in an industrial manner by Ovofood, Herk-de-Stad, Belgium.
Every patient receives 1 plastic straw and 18 tubes with screw cap from the test kit. The test is preferably executed in the morning (at starvation). The patients stay in rest during the test, although a slow walk is permitted. They stay in upright position the first two hours of the test; after that time more conformable position may be adopted, but never they are allowed to lie down. To provide a breath sample, the patients keep the $trftW->£t the Bottom cφftfae |tube, they inhale deeply and expirate 5 seconds through the straw. The tube is immediately closed thereafter. The test is performed as follows:
Before ingestion of the pancake the patients blow in the first vial and half a minute thereafter in vial 2. The pancake is eaten within 10 minutes. As drink (150-ml) only water, coffee or tea is allowed. Coffee or tea can be creamed and/or sweetened, but not with cane sugar. A soft drink or fruit juice is not allowed. During the test, small quantities (20 ml) of drinks can be taken, just to cut thirst. 15 minutes after the end of the meal the patients blow in the next tube. 30 minutes after the end of the meal the patients blow into tube 4. Every 15 minutes thereafter the patients blow in the next tube, up to 4 hours (240 min). The test end after 4 hours.
Analysis of the tubes: l3C contents in breath is determined by on line gas chromatographic purification-isotope ratio mass spectrometry (ABCA; Europe Scientific). The 6 value given by the isotope ratio mass spectrometry are converted to percentage 13C recovery of the initial amount administered per hour (% dose 13C/h) according to calculations described in detail by Ghoos et al (5)
Statistics: Analysis of variance on average tl/2 - value is done (ANOVA-test). The level of significance is set at p< 0.05. The program used was SAS/STAT release 6.03 Edition 1 (SAS institute Inc. Raleigh, NC)
Results: In the following table the values of test results are shown, following the four groups
Table I: group A group B group C group D n = 42 10 16 8
1 1 2 (mean) 72 68 80 71 sd 22 27 21 18
+ 2 sd 118 122 122 107
- 2 sd 20 14 38 35
Statistical evaluation: No significance level was reached. Example 3 Comparison of premix pancake
Figure imgf000009_0001
test to the classical egg & bread meal in healthy subjects in a paired set up
Methods: Sixteen healthy subjects were included in this study. None of them had gastrointestinal complaints. On different occasions (at least 2 days apart) each of them performed two breath tests. Test I involved the classic gastric emptying breath test meal. In the preparation of this meal, 100 μl 13C-octanoic acid is mixed in one egg yolk. This yolk is then baked in a pan and then the white of the egg is added to bake. The meal is eaten in maximum 10 minutes with 3 slices of white bread and 1 glass (150 ml) of water. Test II involved the dry premix in which 100 μl of 13C-octanoic acid is already integrated per egg yolk in an industrial setup through freeze drying. To this mix (1 sachet = 33 g) 70 ml water is added and mixed. The so obtained batter was then baked in a pan with 3 g of margarine. The subject ate the pancake with 5 g of caster sugar in maximum 10 minutes and with a glass of water. Breath samples were taken via a drinking straw held inside a tube (exetainer). Before the meal 2 samples were obtained and after the meal every 15 minutes for a total duration of 4 hours. Samples were measured by continuous flow isotope ratio mass spectrometry (ABCA 20-20, PDZ Europas, Crewe, UK). From the obtained deltal3 values the Percent Dose Recovery was calculated and a model was fit by the method of least squares. From this method the time of half emptying of the stomach (tl/2g) was calculated including a correction for post gastric processing of the label. The calculation method has previously been described (Maes et al, J Nucl Med 1994, 35:824-831) (Ghoos et al, Gastroenterology 1993, 104(6): 1640-1647). Statistical evaluation was performed by the Altman-Bland method, in which in a graph the difference between methods is plotted against the mean of methods. Mean difference and correlation of difference to mean are calculated.
Results: In figure 1 individual paired data for gastric half emptying time are given. Data from one subject were omitted, because of an apparently outlying value for gastric half emptying time in test I in this subject. For test I mean and standard deviation were 82 min and 17 min respectively. In test II these values were 79 and 22 minutes. In figure 2 the Altman-Bland plot for these data is shown. The mean difference in tl/2g between both tests was -3 minutes (test II - test I), which was not significantly different from 0. The correlation between difference and mean was found to be r=0.227, which was not significant. Discussion/Conclusion: Test with the dry premix used to bake a pancake as a meal in the 13C- octanoic acid breath test for gastric emptying was found to yield comparable results to the established egg & bread meal, used in most studies in literature. Altman-Bland plot and - analysis showed no significant mean difference in gastric half emptying time from both tests and no significant correlation of difference between tests with mean of tests. The latter indicates there is no systematic deviation between both tests for high or low values in tl/2g. The use of the dry pancake mix with integrated marker molecule is therefore a valid alternative, making test execution easier for the patient and possible in an ambulatory way, while preserving the advantages of the breath test over other techniques like scintigraphy. The test using an egg yolk has proven its quality in a specialised laboratory set up, but the preparation of the meal in that case does not make it a robust test. Meal preparation in the egg and bread test is very critical because of the difficult integration of the marker molecule in the meal and may give rise to faulty execution of the breath test and thereby yield erroneous results. The development of the premix containing 13C-octanoic acid, integrated via lyophilisation with egg yolk, overcomes this major problem. In that way the breath test for gastric emptying of solid food does become a robust, easy to perform test.
DISCUSSION By comparative studies is has been demonstrated that there is no statistical difference when the omelet meal is replaced by the pancake to measure gastric emptying by 13CO2 breath test. The pancake meal shows great advantages over the omelet meal. It is no longer necessary that the patient presents to the hospital to execute the breath test. Even the test can be done at home, when the patient is properly instructed. The breath samples have to be sent to the analytical unit, and the test results are sent to the medical doctor, who informs the patient. By this method it will be easier in the future to study the influence of pharmacological modulation of gastric emptying as the test meal is uniform for all individuals involved in the study, and as the test can be executed over the world, wherever wanted. As the powder keeps fresh over a long time, clinical investigations and pharmacological effects can be planned over a widespread period. This meal enables to present the 13CO2 breath test for gastric emptying as a test-kit, which makes the whole procedure uniform and repeatable for all persons, to whom the test can be applied. In conclusion: The proposed method, which gives rj;«ty)<tf?Qmilπr a thr rfi M method, can be considered very reliable to measure gastric emptying of solids, as the egg omelet method provides an excellent correlation between gastric half-emptying time (r= 0.98) and log phase (r=0.85), determined via 13CO2 breath test and radioscintigraphy, which is classically considered to be a reference method (3). The pancake method to study gastric emptying by means of the 13CO2 breath test offers great advantage over other test meals. It is foreseen that the proposed pancake test meal will have great acceptance in clinical practice and research.
Fields of applications: The presented test can be applied in all categories of the population, children, adults, pregnant women, elderly people. in clinical diagnostic context:
Measuring gastric emptying in children, adults and elderly people in the hospital. The test can be sent to other hospitals as a test-kit , and can even be taken at home to have the test done by the patient at the time, which is the most convenient for him(her). in research context:
- in clinical research: the test can be considered reference method to demonstrate gastric emptying in different pathological conditions. To the presented test meal (pancake powder) other tracer molecules can be added to study gastrointestinal functions, other than gastric emptying, e.g. assimilation of carbohydrates, lipids, proteins, oro-cecal transit, bacterial overgrowth or/and fermentation processes in the colon.
- in . pharmaceutical research: the test can be taken as reference method for testing and developing drugs, affecting gastrointestinal motility and transit.
- in nutritional research: the test can also be taken as reference method to demonstrate gastric emptying of food formula.
REFERENCES
1) Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele Ml, Rutgeerts PJ, Vantrappen G Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993 Jun; 104(6): 1640- 7
2) Maes B.D., Ghoos Y.F., Geypens B.J., Mys G, Hiele M.I., Rutgeerts P.J., Vantrappen G. : Combined carbon 13 -gly cine/carbon- 14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J. Nucl. Med. 35: 824-831, 1994. 3) Maes B., Mys G., Geypens B., Evenepoel P., xdth όd Y.. Rutseert^ J Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results. Am. J. Physiol., 275, G169 - G175, 1998
4) Klein Peter D., Measurement of gastric emptying, US5707602, CA2239018, EP0889739, W09735622
5) Ghoos Y, Geypens B., Maes B. et al. Breath tests in gastric emptying and transit studies.- technical aspects of 13C02-breath tests. In: Janssens J, ed. Progress in understanding and management of gastro-intestinal motility disorders. K.U.Leuven: Belgium, 1993: 169 - 80.
6) Iber F. Relative rates of metabolism ofMCT, LCT and ethanol in man. In: Mittelkettige in der Didt, edited by H. Kaunitz, Lang and W. Fekl. Berlin.- Z. Erndhrungswiss, 1974, vol.
17, p 9-16.
7) Mishkin, S. L. Stein, Z. Gatmaitan, and I. M. Arias. The binding of fatty acids to cytoplasmatic proteins.- binding to Z protein in liver and other tissies of rat. Biochem. Biophys. Res. Commun. 83:479 - 485, 1978. 8) Ockner, R. K., J. A. Manning, R.B.Poppenhausen and W.K. Ho A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium and other tissues. Science 177: 56
- 58, 1972. 9) Bremer J. Carnitine and its role in fatty acid metabolism. Trends Biochem. Sci. 2: 207 -
209, 1980. 10) Scheig, R. Hepatic metabolism of medium chain fatty acids. In: Medium Chain
Triglycerides, edited by JR. Senior. Philadelphia, PA: Univeristy of Pennsylvania, 1968, p. 39 - 49. 11) Maes, B.D. Measurement of gastric emptying using dynamic breath analysis, edited by B.
Maes. Leuven, Belgium: Acco 1994. 12) Maes, B.D., Y. F. Ghoos, BJ. Geypens, M.I. Hiele, and P.J. Rutgeerts. Inflence of octreotide on gastric emptying of solids and liquids in normal healthy volunteers. Aliment.
Pharmacol. Ther. 9: 11-18, 1995.
13) Evenepoel P., M Hielle, Geypens B., Geboes K.P., Rutgeerts P. and Ghoos Y. 13C-egg white breath test: a non-invaisve test of pancratic trypsin activity in the small intestine. Gut, January 2000, Vol 46, No 1, p 52-57.
14) Van Den Driessche M, Peeters K, Marien P, Ghoos Y, Devlieger H, Veereman-Wauters G Gastric emptying in formula-fed and breast-fed infants measured with the 13C-octanoic acid breath test. J Pediatr Gastroenterol Nutr. 1999 Jul;29(l):46-51. 15) Maes BD, Hiele MI, Geypens BJ, Ghoos YF, Rutgeerts PJ Gastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy. EurJ Clin Invest 1998 Mar;28( 3): 197-204
16) Maes BD, Geypens BJ, Ghoos YF, Hiele MI, Rutgeerts PJ 13C-Octanoic acid breath test for gastric emptying rate of solids. Gastroenterology 1998
Apr; 114(4).-856-9
17) Pfaffenbach B, Wegener M, Adamek RJ, Wissuwa H, Schaff stein J, Ay gen S, Hennemann
O. Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal—correlation with scintigraphy in diabetic patients and reproducibility in healthy probands. Z Gastroenterol 1995 Mar; 33(3) 141-5
18) Maes BD, Ghoos YF, Rutgeerts PJ, Hiele MI, Geypens B, Vantrappen G
[*C]octanoic acid breath test to measure gastric emptying rate of solids. Dig Dis Sci 1994 Dec;39(12 Suppl):104S-106S
19) Maes BD, Hiele MI, Geypens BJ, Rutgeerts PJ, Ghoos YF, Vantrappen G Pharmacological modulation of gastric emptying rate of solids as measured by the carbon labelled octanoic acid breath test: influence of erythromycin and propantheline. Gut 1994 Mar;35(3):333-7
20) Evenepeol P., Clous D., Geypens B., Hiele M., Geboes K., Rutgeerts P and Ghoos Y. Amount and fate of egg protein escaping assimilation in the small intestine of humans. AM. J. Physiol. 277 G935- G943, 1999

Claims

I . A method of diagnosing gastric emptying of the solid phase in a subject, which comprises the steps of mixing water with C labeled molecules in said a powdered premix, baking said the resulting batter into a solid meal, ingesting said solid meal and measuring 13CO2 in breath samples.
2. The method in accordance with Claim 1 wherein the 13C labeled substrate is a fatty acid.
3. The method in accordance with Claim 1 wherein the l3C labeled substrate is a medium chain fatty acid.
4. The method in accordance with Claim 1 wherein the 13C fatty acid is an octanoic acid.
5. A test kit for carrying out the method of any preceding claims comprising a prepackaged premix.
6. The test kit of claim 5 further comprising tubes with cap and comprising at least 1 straw for blowing.
7. A process for producing said premix of any of the claims 1 to 6 wherein the 13C labeled fraction is obtainable from freeze dried egg yolk.
8. A process for producing said premix of any of the claims 1 to 6 wherein the 13C labeled fraction is obtainable from spray dried egg yolk.
9. The process of the claims 7 or 8, wherein the powdered premix comprises a mixture of said labeled egg yolk with powdered egg white.
10. The process of the claims 7 or 8, wherein the powdered premix comprises a mixture of said labeled egg yolk with powdered egg white, wheat flour and milk powder in suitable amounts to prepare a solid meal.
I I. Use of the premix of any of the claims 1 to 10 to test or develop a medicine that alter gastrointestinal motility or gastrointestinal transit.
12. Use of the premix of any of the claims 1 to 10 to investigate or formulate a diet.
PCT/BE2001/000050 2000-03-27 2001-03-26 Gastric emptying test-kit and method of testing gastric emptying of solid meal Ceased WO2001072342A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001243965A AU2001243965A1 (en) 2000-03-27 2001-03-26 Gastric emptying test-kit and method of testing gastric emptying of solid meal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0007315.5 2000-03-27
GB0007315A GB2360845A (en) 2000-03-27 2000-03-27 Measuring gastric emptying

Publications (1)

Publication Number Publication Date
WO2001072342A1 true WO2001072342A1 (en) 2001-10-04

Family

ID=9888439

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE2001/000050 Ceased WO2001072342A1 (en) 2000-03-27 2001-03-26 Gastric emptying test-kit and method of testing gastric emptying of solid meal

Country Status (3)

Country Link
AU (1) AU2001243965A1 (en)
GB (1) GB2360845A (en)
WO (1) WO2001072342A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094976A1 (en) * 2002-05-10 2003-11-20 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker
WO2004002308A3 (en) * 2002-06-28 2005-09-29 Oridion Breathid Ltd Management of gastro-intestinal disorders
EP1707219A2 (en) 2005-04-01 2006-10-04 Atomic Energy Council - Institute of Nuclear Energy Research Radioactive kits for a gastric emptying measurement
WO2007007100A3 (en) * 2005-07-12 2007-06-28 Leeds Teaching Hospitals Nhs T Measurement of gastric acid secretion
JP2011522898A (en) * 2008-06-10 2011-08-04 アドバンスド ブレス ダイアグノスティクス,リミティド ライアビリティー カンパニー Fluidized bed meal containing marker and method for producing the same
US8178315B2 (en) 2002-05-10 2012-05-15 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker and methods of making
US8231530B2 (en) 2007-05-10 2012-07-31 Advanced Breath Diagnostics, Llc Methods and systems for assessing gastric emptying
US8317718B2 (en) 2007-05-10 2012-11-27 Advanced Breath Diagnostics, Llc Methods of testing digestive functions using both a breath test and a scintigraphy test, and methods of using a breath test as an overall digestive health assessment
US8469899B2 (en) 2002-06-28 2013-06-25 Exalenz Bioscience Ltd. Management of gastro-intestinal disorders
US10772534B2 (en) 2013-03-13 2020-09-15 Advanced Breath Diagnostics, Llc Single-point gastric emptying breath tests

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624516B (en) * 2017-03-20 2022-08-26 华东理工大学 Method for improving metabolite amount in fermentation cells and preparing IDMS standard substance

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009658A1 (en) * 1996-09-05 1998-03-12 Meretek Diagnostics Measurement of liquid phase gastric emptying
WO2000061197A1 (en) * 1999-04-09 2000-10-19 Phenome Sciences Inc. Assessment of gastric emptying disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707602A (en) * 1996-03-25 1998-01-13 Meretek Diagnostics Measurement of gastric emptying

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009658A1 (en) * 1996-09-05 1998-03-12 Meretek Diagnostics Measurement of liquid phase gastric emptying
WO2000061197A1 (en) * 1999-04-09 2000-10-19 Phenome Sciences Inc. Assessment of gastric emptying disorders

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178315B2 (en) 2002-05-10 2012-05-15 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker and methods of making
WO2003094976A1 (en) * 2002-05-10 2003-11-20 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker
AU2003232099B2 (en) * 2002-05-10 2008-11-06 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker
US7785569B2 (en) 2002-05-10 2010-08-31 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker
JP2010222374A (en) * 2002-05-10 2010-10-07 Advanced Breath Diagnostics Llc Lyophilized food including marker
WO2004002308A3 (en) * 2002-06-28 2005-09-29 Oridion Breathid Ltd Management of gastro-intestinal disorders
US8469899B2 (en) 2002-06-28 2013-06-25 Exalenz Bioscience Ltd. Management of gastro-intestinal disorders
EP1707219A2 (en) 2005-04-01 2006-10-04 Atomic Energy Council - Institute of Nuclear Energy Research Radioactive kits for a gastric emptying measurement
WO2007007100A3 (en) * 2005-07-12 2007-06-28 Leeds Teaching Hospitals Nhs T Measurement of gastric acid secretion
US8231530B2 (en) 2007-05-10 2012-07-31 Advanced Breath Diagnostics, Llc Methods and systems for assessing gastric emptying
US8317718B2 (en) 2007-05-10 2012-11-27 Advanced Breath Diagnostics, Llc Methods of testing digestive functions using both a breath test and a scintigraphy test, and methods of using a breath test as an overall digestive health assessment
US8388531B2 (en) 2007-05-10 2013-03-05 Advanced Breath Diagnostics, Llc Methods and systems for assessing gastric emptying
JP2011522898A (en) * 2008-06-10 2011-08-04 アドバンスド ブレス ダイアグノスティクス,リミティド ライアビリティー カンパニー Fluidized bed meal containing marker and method for producing the same
US10772534B2 (en) 2013-03-13 2020-09-15 Advanced Breath Diagnostics, Llc Single-point gastric emptying breath tests

Also Published As

Publication number Publication date
GB2360845A (en) 2001-10-03
GB0007315D0 (en) 2000-05-17
AU2001243965A1 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
AU708697B2 (en) Measurement of gastric emptying
Braden et al. 13C-breath tests: current state of the art and future directions
Buts et al. One-hour blood xylose test: a reliable index of small bowel function
EP1437146B1 (en) Measurement of liquid phase gastric emptying
Tadesse et al. Breath hydrogen (H2) and methane (CH4) excretion patterns in normal man and in clinical practice
WO2001072342A1 (en) Gastric emptying test-kit and method of testing gastric emptying of solid meal
Dahlstrom et al. Serum trace elements in children receiving long-term parenteral nutrition
van Dijk‐van Aalst et al. 13 C mixed triglyceride breath test: a noninvasive method to assess lipase activity in children
Keshavarzian et al. Intestinal Transit in Insulin--Requiring Diabetics.
US6548043B1 (en) Measurement of gastric emptying
AU2003232099B2 (en) Lyophilized edible food incorporating a marker
Berlyne et al. A soluble glucose polymer for use in renal failure and calorie-deprivation states
Alkaabi et al. Effect of traditional Arabic coffee consumption on the glycemic index of Khalas dates tested in healthy and diabetic subjects
Taunton et al. Fructose-1, 6-diphosphatase deficiency, hypoglycemia, and response to folate therapy in a mother and her daughter
Glasgow et al. A comprehensive study of duodenal bile salts in newborn infants and their relationship to fat absorption
US20070014718A1 (en) Kits for gastric emptying measurement
Katerelos et al. Serum levels of retinol, retinol-binding protein, carotenoids and triglycerides in children with β-thalassemia major
Smith et al. Metabolic effects of two triphasic formulations containing ethinyl estradiol and dl-norgestrel
Kim et al. Stable isotope breath test and gastric emptying
Keller et al. European guideline on indications, performance and clinical impact of
Keshavarzian et al. Carbohydrate malabsorption in alcoholic pancreatic insufficiency
Loriaux et al. Glycine loading test in acute intermittent porphyria patients and their relatives
Barillas‐Mury et al. Variance in fasting breath hydrogen concentrations in Guatemalan preschool children
WO2002062399A1 (en) Gastric emptying
Shaban The Effect of Consumption of Cassava and Cassava Products on Blood and Urine Glucose Levels in Adult Diabetic Patients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP